Sasol is expanding its Brunsbüttel site with a €60 million investment to boost specialty alumina production and strengthen supply for critical catalyst applications. Operations targeted for 2029.
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.